CVPath Institute Inc
@CVPath_Md
Followers
273
Following
81
Media
33
Statuses
194
CVPath provides consultation, histology, and diagnostic services to promote discoveries that advance diagnosis and treatment of cardiovascular diseases.
Gaithersburg
Joined November 2017
Come read our latest article reviewing the spectrum of macrophage phenotypes and how they contribute to atherosclerotic plaque development and progression. https://t.co/6a9HLb3EyR
pubmed.ncbi.nlm.nih.gov
Various signals derived from atherosclerotic lesions drive macrophages into complex subsets with different gene expression profiles, phenotypes, and functions, not all of which are understood....
0
1
5
Our new publication aimed to quantify the frequency of embolic debris captured by the SENTINEL-CPS in lower-risk TAVR cases.
pubmed.ncbi.nlm.nih.gov
Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study
0
2
2
Read our review article for a deeper understanding of sex differences and the risk factors of coronary atherosclerosis that may lead to improved outcomes of CVD in women. Sex Differences in Coronary Atherosclerosis
pubmed.ncbi.nlm.nih.gov
Traditional risk factors contribute to coronary artery disease (CAD) differently in women and men. There are female-specific risk factors and comorbid conditions that affect the risk of CAD. Plaque...
0
0
3
Our new publication highlighting the importance of cytokine storm-related hypercoagulation in the pathogenesis of stent thrombosis in patients with SARS-CoV-2: Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity
pubmed.ncbi.nlm.nih.gov
Blood-biomaterials interactions may determine the thrombogenic potential of stents. Under simulated cytokine storm conditions, fluoropolymer-coated stents showed the most favorable anti-thrombogenic...
0
0
2
Dr Kenji Kawai presents at #CRT2022 “Use of the Pulse NanoMed System to Facilitate Chronic Total Occlusion Recanalization and Reconstitution in Cadaver Limbs”
0
0
2
Dr Kenji Kawai (CVPath Fellow) presented at #CRT2022 “Acute Stent Thrombogenicity In The Transition From DAPT To SAPT In An Ex Vivo Pig Blood Flow Loop System” which was awarded best abstract
0
0
2
CVPath’s presence was prominent at #CRT2022. Dr Aloke Finn, Medical Director, presented a plethora of talks.
0
0
3
Check out the recently published article, a study led by Dr. Anne Cornelissen, in Future Cardiology, indicating the significance of COBRA PzF nanocoated coronary stents. https://t.co/KHyE5OGWDY
0
3
3
Congratulations to CVPath's Founder and President Dr. Renu Virmani who has been awarded the 11th TCTAP Award “Master of the Masters”! https://t.co/llnKcrc8li
3
3
25
CVPath used an AWS-powered platform for the data in our research on cardiac injury in COVID-19 patients, discussed in more detail on the AWS Public Sector Blog. Learn more about the platform's role in our research and the conclusions that followed:
aws.amazon.com
We’ve helped multiple nonprofit research organizations advance their COVID-19 research through our AWS Diagnostic Development Initiative, first launched in March 2020. The next round of funding opens...
0
0
2
Featured in @JACCJournals is a recent study led by Yu Sato and Sho Torii on calcified nodules as a cause of coronary thrombosis. The full article can be found here: https://t.co/HETGTQXVSV
0
1
4
great summary by @lamckeown1 @TCTMD of our recent JACC review on pathological evidence for COVID-19 induced myocarditis @CVPath_Md
The incidence of COVID-19-related myocarditis was less than 5% in this systematic review of published literature. @AlokeFinn #COVID19 #cardiopath
0
1
5
Review Shows Little Risk for Myocarditis in COVID-19 https://t.co/k7QfTvQpWA via @medscape @JACCJournals
medscape.com
Myocarditis has an 'extremely low frequency' in the setting of COVID-19 and biopsy is not recommended, concludes a review of published cases to date.
0
1
4
JACC Review Topic of the Week: “Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis” from CVPath’s Rika Kawakami, MD, and Atsushi Sakamoto, MD. https://t.co/bm6V13c0QY
0
0
2
Congratulations to Dr. Renu Virmani from CVPath Institute, who has recently been noted as one of the Clarivate 2020 Highly Cited Researchers for publications ranking in the top 1% by citations for field and year. #HighlyCited2020
clarivate.com
The Highly Cited Researchers 2025 list identifies and celebrates individuals who have demonstrated significant and broad influence in their fields of research. Through rigorous selection criteria and...
0
2
12
New publication from lead authors, and former CVPath fellows, Hiroyuki Jinnouchi and Fumiyuki Otsuka: “Healthy Strut Coverage After Coronary Stent Implantation: An Ex Vivo Human Autopsy Study.” https://t.co/wH2KAVlLyI
ahajournals.org
Background: Struts have been considered as covered when tissue overlying the struts is >0 μm by optical coherence tomography (OCT). However, there is no confirmatory study to validate this definition...
0
0
2
If you missed TCT Connect 2020, here's a review on CVPath’s recently published paper from @AlokeFinn and research fellow Yu Sato. During Sunday's session, Yu presented findings on the significance of treating accessory arteries in renal denervation:
tctmd.com
This analysis of tissues from human autopsies hints that further BP reductions can be achieved with this approach.
0
2
3
Interested in CVPath presentations @TCTConference? A full list of our activities https://t.co/AQ4W9fostr Congratulations to our fellow Yu Sato for presenting his work at Late Breaking Clinical Science on Oct 18 on accessory renal nerves! Don't miss Dr. Virmani at LBCT Oct 14th!
cvpath.org
CVPath Institute will be participating in the annual TCT Connect conference, October 14th – 18th, a worldwide educational event for cardiovascular research and training.
0
4
9